Search results
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 4 days agoDepartment of Health and Human Services, could total several tens of millions of dollars and include...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 3 days agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Moderna's RSV vaccine for older adults approved
Axios· 3 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 3 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 5 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 4 days ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 4 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 3 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 3 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
US government, Moderna nearing deal for bird flu vaccine funding: reports
The Hill via Yahoo News· 4 days agoThe U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA ...